(Q27853070)

English

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study

scientific article

Statements

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study (English)
1 reference
0 references
0 references
Joyce F Liu
0 references
William T Barry
0 references
Michael Birrer
0 references
Jung-Min Lee
0 references
Ronald J Buckanovich
0 references
Gini F Fleming
0 references
Bj Rimel
0 references
Mary K Buss
0 references
Sreenivasa Nattam
0 references
Jean Hurteau
0 references
Weixiu Luo
0 references
Philippa Quy
0 references
Christin Whalen
0 references
Lisa Obermayer
0 references
Hang Lee
0 references
Elise C Kohn
0 references
S Percy Ivy
0 references
October 2014
0 references
15
0 references
1207-14
0 references
11
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit